Alphonse G Taghian is an expert in Radiotherapy at Massachusetts General Hospital (United States). As of May 2026, ScienceLeadR ranks Alphonse G Taghian in the top 1% of experts worldwide for Breast Diseases and Breast Neoplasms. Alphonse G Taghian has authored 400 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 1 of them ongoing. SLR score: 1,574 (community average: 125). How the SLR is computed.

LeadR Profile

Alphonse G Taghian Massachusetts General Hospital United States
1 574 ScienceLeadR Reputation 1574
Network Map

Radiotherapy

Subspecialties: Oncology - Surgery - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1990 - 2026

Source: PubMed

Massachusetts General Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 400

Citations

Citations: 16 418 1st author: 42 Last author: 191 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial.
PMID 42114027 — conservative treatment, breast neoplasms, neoplasms, mastectomy, segmental, breast, therapeutics
J Clin Oncol Top journal20260
When Postmastectomy Radiotherapy (PMRT) is not Really PMRT: A Critical Evaluation of SUPREMO Trial.
PMID 41803583 — radiotherapy
Ann Surg Oncol20260
Integration of Breast Reconstruction and Radiation: How the Proton-Photon Debate Exposes Methodological Gaps, Analytical Bias, and Lack of Consensus.
PMID 41759681 — bias, mastectomy, proton therapy, radiobiology, mammaplasty, breast, therapeutics
Int J Radiat Oncol Biol Phys20260
Clinical Hypothyroidism after Proton versus Photon Regional Nodal Irradiation: A Prospective Correlative Study within the RADCOMP Randomized Trial.
PMID 41692352 — radiotherapy, incidence, thyroid gland, hypothyroidism, therapeutics
Int J Radiat Oncol Biol Phys20260
Analysis of factors associated with loco-regional failure in breast cancer patients following neoadjuvant chemotherapy.
PMID 41288781 — mastectomy, breast neoplasms, neoplasms, drug therapy, breast, chemotherapy
Breast Cancer Res Treat20250

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 7

By phase:

N/A 12

By status:

Active not recruiting 4
Completed 4
Not yet recruiting 1
Recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 9
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 2
multicentric5to9 0
multicentricup10 3

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Early Intervention
NCT05326165 — pilot projects, pilots, gloves, protective, breast neoplasms, early intervention, educational, neoplasms, breast cancer lymphedema, breast, therapeutics, clothing, lymphedema
N/ANot yet recruiting2027

LeadR Networks

Main global connection map